Today’s stock pick update – Open Now

Learn More

Tiny Massachusetts Company Awarded $75 Billion Patent

Tiny biotech's breakthrough proves it's possible to remove cancer cells from sick patients. Bill Gates says new discovery is so powerful it could "help humanity." This under-the-radar company is not yet a household name.(Ad)

Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>

The Commerce Department Just Moved To Ban TikTok & WeChat From U.S. App Stores Starting Sunday

Blocked. The U.S. moved to expel the Chinese-owned TikTok and WeChat apps from U.S. app stores as of Sunday, while reserving the right to reverse a ban on TikTok’s video-streaming service once it can hammer out a deal to satisfy national security concerns. “At the President’s direction, we have taken significant action to combat China’s malicious collection of American citizens’ personal data, while promoting our national values, democratic rules-based norms, and ag...

Read More

Rigel Pharmaceuticals (NASDAQ: RIGL): Rigel Pharmaceuticals shares gained as much as 16% yesterday after the company announced the start of its Phase 2 trial to evaluate the safety of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of hospitalized COVID-19 patients. The study is sponsored by the National Heart, Lung, and Blood Institute (NHLBI). ”...

Read More

Is MPLX a smart bet on U.S. energy pipelines?

It’s true that the global COVID-19 pandemic is an easy one to think about, simply because the virus is proving to be a much more prolonged issue than many hoped; but for today’s highlight I’m talking about a different storyline – one that extends all the way back into 2018 and specifically impacts the energy sector.


Read More

OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor.


Read More

Already subscribed to our premium service?

Click here to Login.

Not a TradersPro subscriber yet?

Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

This email was sent to phanhoa1821960.trader@blogger.com 
by TradersPro Investiv, LLC
265 N. Main | Ste. D #283
Kaysville | UT | 84037

Unsubscribe or Mange which emails you get from TradersPro
 
All trading carries significant risk. Please see our full risk disclaimer.


Disclaimers, Terms & Conditions | Privacy Policy

Copyright © 2020

 

No comments:

Post a Comment